Cibc World Market Inc. Essa Pharma Inc. Transaction History

Cibc World Market Inc.

$43.4 Billion
Q2 2024

A detailed history of Cibc World Market Inc. transactions in Essa Pharma Inc. stock. As of the latest transaction made, Cibc World Market Inc. holds 80,257 shares of EPIX stock, worth $543,339. This represents 0.0% of its overall portfolio holdings.

Number of Shares

80,257

Previous 80,857 0.74%

Holding current value

$543,339

Previous $686,000 38.48%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	SELL	$4.63 - $8.42 $2,778 - $5,052	-600 Reduced 0.74%	80,257 $422,000
Q1 2024 May 13, 2024	SELL	$6.17 - $10.65 $190,301 - $328,477	-30,843 Reduced 27.61%	80,857 $686,000
Q4 2023 Feb 13, 2024	SELL	$2.74 - $7.35 $102,593 - $275,206	-37,443 Reduced 25.11%	111,700 $737,000
Q3 2023 Nov 13, 2023	SELL	$2.65 - $3.31 $30,475 - $38,065	-11,500 Reduced 7.16%	149,143 $461,000
Q2 2023 Aug 11, 2023	SELL	$2.6 - $3.34 $125,184 - $160,814	-48,148 Reduced 23.06%	160,643 $434,000
Q1 2023 May 12, 2023	BUY	$2.56 - $3.55 $110,464 - $153,182	43,150 Added 26.05%	208,791 $620,000
Q4 2022 Feb 13, 2023	BUY	$1.5 - $4.82 $132,607 - $426,112	88,405 Added 114.46%	165,641 $417,000
Q3 2022 Nov 10, 2022	SELL	$1.75 - $3.44 $30,348 - $59,656	-17,342 Reduced 18.34%	77,236 $141,000
Q2 2022 Aug 10, 2022	SELL	$3.15 - $7.94 $65,060 - $163,992	-20,654 Reduced 17.92%	94,578 $298,000
Q1 2022 May 12, 2022	BUY	$6.18 - $14.44 $191,592 - $447,668	31,002 Added 36.81%	115,232 $712,000
Q4 2021 Feb 14, 2022	BUY	$7.8 - $14.38 $656,994 - $1.21 Million	84,230 New	84,230 $1.2 Million
Q1 2021 May 11, 2021	SELL	$11.61 - $32.08 $116,680 - $322,404	-10,050 Closed	0 $0
Q2 2018 Aug 08, 2018	BUY	$3.2 - $4.74 $32,160 - $47,637	10,050 New	10,050 $38,000

Others Institutions Holding EPIX

# of Institutions

Shares Held

35.2M

Call Options Held

37.7K

Put Options Held

3.8K

View Full List

About ESSA Pharma Inc.

Ticker EPIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,073,100
Market Cap $298M
Description
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreem...

More about EPIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc World Market Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cibc World Market Inc. with notifications on news.

Account

Cibc World Market Inc. Essa Pharma Inc. Transaction History